z-logo
open-access-imgOpen Access
Regione “Test”
Author(s) -
Roberto Gasparini,
Donatella Panatto,
Bruna Dirodi,
Rosa Prato,
Gianni Amunni,
Valter Turello,
Luigi Sudano,
Paolo Cristoforoni,
Sara Boccalini,
Paolo Bonanni
Publication year - 2012
Publication title -
farmeconomia health economics and therapeutic pathways
Language(s) - English
Resource type - Journals
eISSN - 1721-6923
pISSN - 1721-6915
DOI - 10.7175/fe.v13i2s.471
Subject(s) - cohort , test (biology) , medicine , demography , meaning (existential) , vaccination , pediatrics , psychology , sociology , virology , paleontology , psychotherapist , biology
In “Test” region 75% of women (aged 24-64) are screened regularly, meaning every 3 years. A cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 50% coverage, even if the coverage is much lower than 90%, could prevent 8 cases of cervicocarcinoma and 4 related deaths more than the vaccination of only 12-year-old girls, and thus proves to be cost-effective (8,721 €/QALY)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom